Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-26-005776
Filing Date
2026-02-09
Accepted
2026-02-09 16:15:04
Documents
4
Period of Report
2026-02-09

Document Format Files

Seq Description Document Type Size
1 6-K form6-k.htm 6-K 19862
2 EX-99.1 ex99-1.htm EX-99.1 47894
3 EX-99.2 ex99-2.htm EX-99.2 21921
4 GRAPHIC ex99-2_001.jpg GRAPHIC 721
  Complete submission text file 0001493152-26-005776.txt   91919
Mailing Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608
Business Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 26611593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)